2.16 +0.00 (0.00%)
CLRT
Stock Details
Last Trade:2.16 Change:+0.00 (0.00%) Prev Close:2.16 Open: 2.20 Days Range:2.15 – 2.25 52 Week Range: 1.42 - 4.43 Volume:243702 P/E: N/AEPS:-0.16
View AllRecent Alerts 02/10/10
Recent Alert on 01/08/10 at 9:24am
ThinkEquity Initiates Coverage on Clarient (CLRT) with a Buy
ThinkEquity Initiates Coverage on Clarient (CLRT) with a Buy
ThinkEquity initiates coverage on Clarient (Nasdaq: CLRT) with a Buy. To see all the upgrades/downgrades on shares of CLRT, visit our Analyst Ratings page. Clarient, Inc. (Clarient) is an oncology diagnostics services company.
Recent Alert on 12/23/09 at 2:45pm
Clarient (CLRT) Files a 25.52M Common Shelf for Selling Shareholders
Clarient (CLRT) Files a 25.52M Common Shelf for Selling Shareholders
Recent Alert on 12/22/09 at 10:45am
Morning Movers 12/22: CICC, AAC, WAVE, ATHX, YRCW, SHS, ADES Higher; GIGM, CMC Lower
Morning Movers 12/22: CICC, AAC, WAVE, ATHX, YRCW, SHS, ADES Higher; GIGM, CMC Lower
Recent Alert on 12/21/09 at 5:24pm
After-Hours Movers 12/21: CLRT, JBL, PDLI, BYD Higher; ZGEN, TTWO, JSDA, TRV, CEPH Lower
After-Hours Movers 12/21: CLRT, JBL, PDLI, BYD Higher; ZGEN, TTWO, JSDA, TRV, CEPH Lower
Recent Alert on 12/21/09 at 4:08pm
Clarient (CLRT) Acquires Applied Genomics in $17.6M Stock Transaction
Clarient (CLRT) Acquires Applied Genomics in $17.6M Stock Transaction
View AllRecent Press Releases
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 10/14/09 at 6:47am
With Promising Cancer Drugs, Genomic Must Still Diversify Its Pipeline
With Promising Cancer Drugs, Genomic Must Still Diversify Its Pipeline